LINC01194

Across TCGA pan-cancer cohorts, LINC01194 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC01194’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC01194 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01194 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LIHC, HNSC, and BRCA are the cancer types where LINC01194 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01194 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.684	<.001	8	view →
HNSC	All	All	+0.201	.011	4	view →
BRCA	Female	All	+0.161	.004	4	view →
LUSC	All	All	+0.624	<.001	3	view →
LUAD	All	All	+0.324	.005	3	view →
PRAD	All	All	+0.165	.031	2	view →
STAD	All	All	+0.396	.044	1	view →
THCA	Female	All	−0.015	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC01194–LIHC

Open the LIHC breakdown →